Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	94.99	113.02	94.9	61.06	27.19	10.18
Depreciation & Amortization	29.28	26.68	13.39	6.31	6.51	5.81
Other Operating Activities	35.59	25.64	34.37	22.74	10.98	11.93
Change in Accounts Receivable	34.31	-50.21	-0.4	-39.05	-30.21	-34.54
Change in Inventory	-15.66	-49.77	-33.56	-69.77	-19.4	-27.14
Change in Accounts Payable	-10.31	-23.15	-49.89	-0.62	53.98	25.25
Change in Other Net Operating Assets	46.91	-170.64	30.37	143.07	19.11	31.76
Operating Cash Flow	209.58	-130.44	85.9	117.96	68.16	23.25
Operating Cash Flow Growth	-	-	-27.18%	73.06%	193.22%	691.28%
Capital Expenditures	-180.67	-35.12	-74.66	-47.27	-46.05	-11.06
Other Investing Activities	141.86	-2.38	27.07	-18.59	0.18	0.32
Investing Cash Flow	-329.58	-37.94	-49.56	-66.32	-45.91	-10.78
Issuance of Common Stock	-	252.57	-	-	-	-
Other Financing Activities	149.87	-24.87	-31.05	-17.03	-11.24	-12.3
Financing Cash Flow	149.87	227.7	-31.05	-17.03	-11.24	-12.3
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-
Net Cash Flow	29.87	59.32	5.28	34.62	11.01	0.18
Free Cash Flow	28.91	-165.55	11.23	70.69	22.11	12.18
Free Cash Flow Growth	-	-	-84.11%	219.67%	81.51%	17916.59%
Free Cash Flow Margin	1.84%	-12.21%	0.98%	7.13%	4.04%	3.34%
Free Cash Flow Per Share	2.08	-11.90	1.10	6.95	2.17	1.20
Cash Interest Paid	27.01	21.91	31.05	14.4	11.24	12.3
Cash Income Tax Paid	32.13	36.72	31.2	19.57	10.47	3.76
Levered Free Cash Flow	84.14	-34.52	-107.44	-69.66	-10.24	-33.3
Unlevered Free Cash Flow	99.12	-22.73	-89.98	-60.66	-4.52	-29.96
Change in Net Working Capital	-163.84	113.81	120.68	78.53	-6.89	40.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.